BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8268887)

  • 1. Angiotensin II antagonists.
    Brunner HR; Nussberger J; Burnier M; Waeber B
    Clin Exp Hypertens; 1993 Nov; 15(6):1221-38. PubMed ID: 8268887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II antagonists DuP 753 and TCV 116.
    Brunner HR; Delacrétaz E; Nussberger J; Burnier M; Waeber B
    J Hypertens Suppl; 1994 Nov; 12(9):S29-34. PubMed ID: 7884581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy.
    Eberhardt RT; Kevak RM; Kang PM; Frishman WH
    J Clin Pharmacol; 1993 Nov; 33(11):1023-38. PubMed ID: 8300885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.
    Goldberg MR; Bradstreet TE; McWilliams EJ; Tanaka WK; Lipert S; Bjornsson TD; Waldman SA; Osborne B; Pivadori L; Lewis G
    Hypertension; 1995 Jan; 25(1):37-46. PubMed ID: 7843751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The advantages of angiotensin II antagonism.
    Burnier M; Waeber B; Brunner HR
    J Hypertens Suppl; 1994 Jul; 12(2):S7-15. PubMed ID: 7965267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the angiotensin II receptor antagonist Losartan (DuP 753/MK 954) on arterial blood pressure, heart rate, plasma concentrations of angiotensin II and renin and the pressor response to infused angiotensin II in the salt-deplete dog.
    MacFadyen RJ; Tree M; Lever AF; Reid JL
    Clin Sci (Lond); 1992 Nov; 83(5):549-56. PubMed ID: 1335390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system.
    Brunner HR; Nussberger J; Waeber B
    J Hypertens Suppl; 1993 Apr; 11(3):S53-8. PubMed ID: 8315521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with angiotensin II receptor antagonists.
    Lee RJ; Brunner HR
    J Hum Hypertens; 1993 Aug; 7 Suppl 2():S33-6. PubMed ID: 8230087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats.
    Schnecko A; Witte K; Lemmer B
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):214-21. PubMed ID: 7475045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of losartan (DuP 753)-induced angiotensin II receptor antagonism by PD123177 in rats.
    Wong PC; Christ DD; Timmermans PB
    Eur J Pharmacol; 1992 Sep; 220(2-3):267-70. PubMed ID: 1425998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiotensin II receptor blockade during exercise: comparison of losartan and saralasin.
    Symons JD; Stebbins CL
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):223-31. PubMed ID: 8856477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor antagonism: losartan - sites and mechanisms of action.
    Triggle DJ
    Clin Ther; 1995; 17(6):1005-30. PubMed ID: 8750395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade.
    Camargo MJ; von Lutterotti N; Campbell WG; Pecker MS; James GD; Timmermans PB; Laragh JH
    J Hypertens; 1993 Jan; 11(1):31-40. PubMed ID: 8382237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiotensin-II receptor blockers].
    Metelitsa VI
    Ter Arkh; 1996; 68(8):64-7. PubMed ID: 9019837
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure.
    Gottlieb SS; Dickstein K; Fleck E; Kostis J; Levine TB; LeJemtel T; DeKock M
    Circulation; 1993 Oct; 88(4 Pt 1):1602-9. PubMed ID: 8403307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin antagonists.
    Brunner HR; Nussberger J; Waeber B
    Adv Nephrol Necker Hosp; 1993; 22():305-27. PubMed ID: 8427061
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist.
    Munafo A; Christen Y; Nussberger J; Shum LY; Borland RM; Lee RJ; Waeber B; Biollaz J; Brunner HR
    Clin Pharmacol Ther; 1992 May; 51(5):513-21. PubMed ID: 1587065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with angiotensin II receptor antagonists.
    Brunner HR; Christen Y; Munafo A; Lee RJ; Waeber B; Nussberger J
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):243S-246S. PubMed ID: 1290619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.